This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (7) Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Mak, A Articles by Au, T C Search for Related Content PubMed PubMed Citation Articles by Mak, A Articles by Au, T C Social Bookmarking                         What's this?

Renal damage in systemic lupus erythematosus: a comparative analysis of different age groups

Department of Medicine and Geriatrics, Tuen Mun Hospital, Tsing Chung Koon Road, Hong Kong SAR

C C Mok

Department of Medicine and Geriatrics, Tuen Mun Hospital, Tsing Chung Koon Road, Hong Kong SAR; ccmok2005{at}yahoo.com

W P Chu

Department of Pediatrics and Adolescence Medicine, Tuen Mun Hospital, Tsing Chung Koon Road, Hong Kong SAR

C H To

Department of Medicine and Geriatrics, Tuen Mun Hospital, Tsing Chung Koon Road, Hong Kong SAR

S N Wong

Department of Pediatrics and Adolescence Medicine, Tuen Mun Hospital, Tsing Chung Koon Road, Hong Kong SAR

T C Au

Department of Medicine and Geriatrics, Tuen Mun Hospital, Tsing Chung Koon Road, Hong Kong SAR

The objective of this study was to compare the frequency and severity of renal damage in systemic lupus erythematosus (SLE) with regard to the age of disease onset. Among 287 patients with new onset SLE diagnosed between 1991 and 2003 in our hospital, we identified those who fulfilled the American College of Rheumatology (ACR) criteria for renal involvement. Patients were categorized into childhood (age <6 years), adult (between 16 and 50 years) or late onset (50 years) SLE. Clinical presentation of renal disease and cumulative renal damage as assessed by the renal domain of the Systemic Lupus International Collaborating Clinics/ACR damage index (SDI) were compared. A linear regression model was constructed to study the effect of age on renal damage. One-hundred and forty-nine patients were studied (134 women and 15 men), including 28 childhood, 107 adult and 14 late onset SLE patients. The mean age of SLE onset was 29.7 ± 14 years. The prevalence of renal disease was 53% in childhood onset, 50% in adult onset and 58% in late onset SLE patients (P = 0.66). At renal disease presentation, late onset SLE patients had significantly lower creatinine clearance and were more likely to be hypertensive. Histological classes of nephritis and initial treatment response, however, did not differ significantly among the patients. After a mean observation of 80.3 months, 32 (21%) patients developed renal damage (renal SDI 1). Late onset SLE patients had accrued more renal damage than the others. In a multiple regression model, age was not a significant determinant of renal damage after adjustment for baseline renal parameters, duration of renal disease, use of cyclophosphamide and initial treatment response. We concluded that the prevalence of renal disease was similar among SLE patients of different ages of onset. Late onset SLE patients had accrued more renal damage but age did not correlate with renal damage after adjustment for various clinical parameters.

Key Words: age • Chinese • damage • lupus nephritis • morbidity

Lupus, Vol. 16, No. 1, 28-34 (2007)
DOI: 10.1177/0961203306074469


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				A. Mak, R. C. M. Ho, and C. S. Lau Clinical implications of neuropsychiatric systemic lupus erythematosus Adv. Psychiatr. Treat., November 1, 2009; 15(6): 451 - 458. [Abstract] [Full Text] [PDF]

				A. Mak, A. A. C. Cheak, J. Y. S. Tan, H. C. Su, R. C. M. Ho, and C. S. Lau Mycophenolate mofetil is as efficacious as, but safer than, cyclophosphamide in the treatment of proliferative lupus nephritis: a meta-analysis and meta-regression Rheumatology, August 1, 2009; 48(8): 944 - 952. [Abstract] [Full Text] [PDF]

				A M Bertoli, L M Vila, J D Reveille, G S Alarcon, and for the LUMINA study group Systemic lupus erythaematosus in a multiethnic US cohort (LUMINA) LIII: disease expression and outcome in acute onset lupus Ann Rheum Dis, April 1, 2008; 67(4): 500 - 504. [Abstract] [Full Text] [PDF]

				A. Mak, B. P. L. Chan, I. B. Yeh, R. C. M. Ho, M. L. Boey, P. H. Feng, D. R. Koh, and B. K. C. Ong Neuropsychiatric lupus and reversible posterior leucoencephalopathy syndrome: a challenging clinical dilemma Rheumatology, March 1, 2008; 47(3): 256 - 262. [Abstract] [Full Text] [PDF]

				G. Contreras and J. Sosnov Role of Mycophenolate Mofetil in the Treatment of Lupus Nephritis Clin. J. Am. Soc. Nephrol., September 1, 2007; 2(5): 879 - 882. [Full Text] [PDF]